• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 22 Oct

    Lexaria Proprietary DehydraTECH-Enabled CBD Powders Business Growing Faster than Expected

    Growth now expected to exceed 500% from fiscal Q4 2020 to fiscal Q1 2021 KELOWNA, BC / ACCESSWIRE / October 22, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in oral drug delivery platforms, is pleased to announce that it is exceeding expectations for volume of servings of… Read More..

    Share this:
  • 21 Oct

    Lexaria Bioscience Granted First European Patent for DehydraTECH Technology

    New patent includes method of treatment claims for a broad range of disease conditions including use of: cannabinoids to treat cardiac conditions such as hypertension and neurological diseases such as Alzheimer's and Parkinson's cannabinoids to treat metabolic disorders and substance abuse and addictions nicotine to treat tobacco dependence/addiction and neurological… Read More..

    Share this:
  • 20 Oct

    HealthLynked Completes Acquisition of MedOfficeDirect, LLC, Adding Discounted Medical Supplies for Patient Members

    NAPLES, Fla., Oct. 20, 2020 /PRNewswire/ -- HealthLynked Corp (OTC: HLYK),  a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients and medical data, today announced that it has acquired MedOfficeDirect, LLC ("MOD"), a Naples, FL based virtual distributor… Read More..

    Share this:
« Previous 1 … 144 145 146 147 148 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact